A student stands over a patient, needle poised. They have a “perfect” prescription: a textbook combination of points harvested from a lecture slide on chronic lower back pain. But as the needle meets the skin, the student hesitates - the symptom of a quiet habit that has taken hold of our profession. We routinely say we “prescribe” points. It sounds efficient. It echoes the authority of biomedical culture and fits neatly into the insurance field. But vocabulary is never neutral; repeated long enough, it dictates behavior.
FDA Publishes New Guide on Supplement Labeling
The Food and Drug Administration's Office of Nutritional Products, Labeling and Dietary Supplements has posted a series of new guidelines on its Web site. Titled A Dietary Supplement Labeling Guide, the guidelines cover a variety of topics related to dietary supplements, including listing and placement of ingredients, health claims, and other issues, and are designed to present the agency's "current thinking" on the labeling of dietary supplements.

"This guidance document appears to be a very thorough review of the federal regulations that need to be considered when labeling a dietary supplement product," said Michael McGuffin, the president of the American Herbal Products Association. "This new guidance should be especially useful to companies that are new to the trade, but will also provide a helpful review for established firms."
The labeling guide is divided into eight chapters and six appendices, with the text in each chapter presented in a question-and-answer format. Topics of discussion include:
- General dietary supplement labeling
- Statement of identity
- Net quantity of contents
- Nutrition labeling
- Ingredient labeling
- Claims
- Premarket notification of new dietary ingredients
- Other labeling information
A Dietary Supplement Labeling Guide is currently available online at www.cfsan.fda.gov/~dms/dslg-toc.html.